You are here

Situation Report

Cuba says its Abdala vaccine is 92.28% effective against coronavirus

Cuba says Abdala vaccine 92.28% effective against coronavirus

HAVANA, June 21 (Reuters) - Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.

The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. ...

The announcement came from state-run biopharmaceutical corporation BioCubaFarma, which oversees Finlay, the maker of Soberana 2, and the Center for Genetic Engineering and Biotechnology, the producer of Abdala.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Coronavirus Delta Variant Could Dominate In U.S. Within Weeks

The dangerous Delta variant of the coronavirus is spreading so quickly in the United States that it's likely the mutant strain will become predominant in the U.S. within weeks, according to a new analysis.

The variant, first identified in India, is the most contagious yet and, among those not yet vaccinated, may trigger serious illness in more people than other variants do, say scientists tracking the spread of infection.

The Delta variant apparently already accounts for at least 14% of all new infections, according to the research analysis posted online Monday of more than 242,000 infections nationwide over the last six months.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO's new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB

WHO releases new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB

17 June 2021

The World Health Organization (WHO) today released updated global lists of high burden countries for tuberculosis (TB), HIV-associated TB and multidrug/rifampicin-resistant TB (MDR/RR-TB). The new lists are for 2021–2025 and replace those previously used between 2016 and 2020.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Situation Report
howdy folks
Page loaded in 1.303 seconds.